Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic.
Mpox cases finding: Evaluation of a Primary Care detection program in the Northern Metropolitan area from Barcelona (Spain).
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.
Multimodal neuroimaging in Long-COVID and its correlates with cognition 1.8 years after SARS-CoV-2 infection: a cross-sectional study of the Aliança ProHEpiC-19 Cognitiu
Long COVID: cognitive, balance, and retina manifestations.
Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model.